Our mission is to revolutionize cancer treatment through precision, targeted radioligand therapy. We aim to leverage our cutting-edge pipeline to unlock the full potential of radioligand therapy across various tumor types, ultimately redefining the future of nuclear medicine.
Headquarters:
France
Company Type:
MNC / Large Enterprise
Company size:
201-500 Employees
Address:
20 RUE DIESEL; SAINT GENIS POUILLY, 01630, FR
HIGH
spending power
